![Gene Therapy for Kids’ Deadly Muscle Disease Fails to Reach Trial Goal](/i/c/4d76c9fd-a449-5896-55b1-ee1e46d16fb6.webp)
Gene Therapy for Kids’ Deadly Muscle Disease Fails to Reach Trial Goal
Roche Holding AG shares dropped after a trial of its gene therapy for Duchenne muscular dystrophy did not
2023-10-31 16:58
![Catalent Is Linked to Regeneron’s Eye-Drug Rejection in Latest Misstep](/i/c/68e2c147-36c2-4b87-95da-2a1f855fe67d.webp)
Catalent Is Linked to Regeneron’s Eye-Drug Rejection in Latest Misstep
Problems at a Catalent Inc. production facility led US regulators to deny a key drug application from Regeneron
2023-06-29 00:29
![Catalent Cuts Annual Forecast More Than Expected, Delays Earnings Report Again](/i/c/1c8e0c74-df63-8d48-9b1d-d11bc23cc28d.webp)
Catalent Cuts Annual Forecast More Than Expected, Delays Earnings Report Again
Catalent Inc. shares rose after the troubled contract drug manufacturer gave investors some reassurance about a slashed fiscal
2023-05-19 22:20
![Drug Contractor Catalent Plunges After Annual Guidance Cut, Results Delayed](/i/c/011aa8ae-341f-50e0-4291-95624d6f7cb4.webp)
Drug Contractor Catalent Plunges After Annual Guidance Cut, Results Delayed
Catalent Inc. shares traded at their lowest in three years following cuts to its annual financial outlook that
2023-05-09 02:28